
“A New Paradigm in Large-Bore Vascular Closure”
About
Arterica is a dynamic medical device startup located in Santa Rosa, California. Founded in 2016, we have assembled a team of highly experienced device innovators along with leading cardiologists and surgeons to improve patient outcomes while lowering heathcare costs.
Large Bore Closure
The trend toward minimally invasive procedures has led to many new catheter-based therapies for cardiovascular disease. An important group of these therapies, including aortic repair (EVAR/TEVAR) and heart valve repair or replacement (TAVR/TMVR), requires large bore catheters to be inserted through the femoral artery or vein. After the procedure, the large access hole in the femoral artery or vein must be closed: that closure is the focus of Arterica.
Key Features of the Arterica System
Extravascular closure – nothing left behind in the artery or vein
Fully functional guidewire left in place until hemostasis is confirmed
Applicable to a wide range of patients, including those with calcified arteries*
Fast, easy deployment
*Data on file at Arterica
Our Experienced Leadership Team
Robert G. Whirley, Ph.D.
President and CEO
25 yrs experience in medtech product development, global regulatory and clinical affairs
Co-founder and former VP, Research & Development, TriVascular
(NASDAQ: TRIV->ELGX)Startup team leadership & financing
Thomas Larzon, M.D., Ph.D.
Chief Medical Officer
Former Chief of Vascular Surgery,
Örebro University Hospital, SwedenPioneer in vascular surgery with 30 years of experience
Global clinical network among vascular specialists
Joseph W. Humphrey, Ph.D.
Chief Operating Officer
Former VP Manufacturing Technology for TriVascular; CFO, corporate development
Developed all PTFE technology
Broad experience in medtech development, manufacturing,
and supply chain